Baseline and 1-year longitudinal data from the National Restless Legs Syndrome Opioid Registry

Abstract

In refractory RLS, prescribed opioids are generally used at low doses with good efficacy. Longitudinally over 1 year, roughly one-third of participants increased their prescribed opioid dose, though generally by small amounts, with larger dose increases accounted for by predictable features.